ZA969315B - Processes and intermediates for the preparation of ziprasidone. - Google Patents

Processes and intermediates for the preparation of ziprasidone.

Info

Publication number
ZA969315B
ZA969315B ZA9609315A ZA969315A ZA969315B ZA 969315 B ZA969315 B ZA 969315B ZA 9609315 A ZA9609315 A ZA 9609315A ZA 969315 A ZA969315 A ZA 969315A ZA 969315 B ZA969315 B ZA 969315B
Authority
ZA
South Africa
Prior art keywords
ziprasidone
intermediates
processes
preparation
Prior art date
Application number
ZA9609315A
Other languages
English (en)
Inventor
Darrell E Fox
John F Lambert
Jr Terry G Sinay
Stanley W Walinsky
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA969315B publication Critical patent/ZA969315B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA9609315A 1995-11-07 1996-11-06 Processes and intermediates for the preparation of ziprasidone. ZA969315B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US630195P 1995-11-07 1995-11-07

Publications (1)

Publication Number Publication Date
ZA969315B true ZA969315B (en) 1998-05-06

Family

ID=21720240

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9609315A ZA969315B (en) 1995-11-07 1996-11-06 Processes and intermediates for the preparation of ziprasidone.

Country Status (29)

Country Link
US (1) US6111105A (es)
EP (1) EP0874834B1 (es)
JP (1) JP3152938B2 (es)
KR (1) KR100315939B1 (es)
CN (1) CN1071324C (es)
AR (2) AR004279A1 (es)
AT (1) ATE198071T1 (es)
AU (1) AU698443B2 (es)
BR (1) BR9611366A (es)
CA (1) CA2236940C (es)
CO (1) CO4480028A1 (es)
CZ (1) CZ290600B6 (es)
DE (1) DE69611253T2 (es)
DK (1) DK0874834T3 (es)
ES (1) ES2152564T3 (es)
GR (1) GR3035215T3 (es)
HU (1) HU225921B1 (es)
MX (1) MX9803599A (es)
MY (1) MY116579A (es)
NO (1) NO309811B1 (es)
NZ (1) NZ318844A (es)
PE (1) PE17298A1 (es)
PL (1) PL185048B1 (es)
PT (1) PT874834E (es)
RU (1) RU2147302C1 (es)
TR (1) TR199800814T2 (es)
TW (1) TW358807B (es)
WO (1) WO1997017336A1 (es)
ZA (1) ZA969315B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27668A1 (es) 2002-02-20 2003-10-31 Pfizer Prod Inc Composición de ziprasidona y controles sintéticos
US20040048876A1 (en) * 2002-02-20 2004-03-11 Pfizer Inc. Ziprasidone composition and synthetic controls
CA2543805A1 (en) 2003-10-24 2005-05-06 Gideon Pilarsky Processes for preparation of ziprasidone
US7777037B2 (en) * 2004-10-27 2010-08-17 Dr. Reddy's Laboratories Limited Ziprasidone process
CN105891392A (zh) * 2016-03-29 2016-08-24 北京万全德众医药生物技术有限公司 一种用液相色谱法分离测定盐酸鲁拉西酮中间体有关物质的方法
CN107064323A (zh) * 2016-12-05 2017-08-18 北京万全德众医药生物技术有限公司 一种用液相色谱法分离测定盐酸鲁拉西酮及其有关物质的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
JPH06220030A (ja) * 1993-01-22 1994-08-09 Sumitomo Pharmaceut Co Ltd 3−アミノ−1,2−ベンズイソチアゾール誘導体の製造法
JP3701044B2 (ja) * 1995-04-24 2005-09-28 住友精化株式会社 シアノベンゼンスルフェニルハライドおよびそれを用いる3−置換ベンゾイソチアゾールの製造方法
JP3996228B2 (ja) * 1996-10-11 2007-10-24 住友精化株式会社 3−ピペラジニルベンズイソチアゾール類の製造法

Also Published As

Publication number Publication date
CO4480028A1 (es) 1997-07-09
MY116579A (en) 2004-02-28
NO309811B1 (no) 2001-04-02
JPH10512595A (ja) 1998-12-02
PL326630A1 (en) 1998-10-12
PE17298A1 (es) 1998-04-16
US6111105A (en) 2000-08-29
AR004279A1 (es) 1998-11-04
NZ318844A (en) 1999-04-29
CA2236940C (en) 2001-08-21
AU698443B2 (en) 1998-10-29
KR100315939B1 (ko) 2002-01-16
CN1201457A (zh) 1998-12-09
EP0874834A1 (en) 1998-11-04
CZ137898A3 (cs) 1999-03-17
EP0874834B1 (en) 2000-12-13
MX9803599A (es) 1998-09-30
NO982051L (no) 1998-07-03
KR19990067381A (ko) 1999-08-16
TR199800814T2 (xx) 1998-07-21
GR3035215T3 (en) 2001-04-30
DE69611253T2 (de) 2001-04-05
HUP9903765A2 (hu) 2000-03-28
PL185048B1 (pl) 2003-02-28
HU225921B1 (en) 2008-01-28
CZ290600B6 (cs) 2002-08-14
TW358807B (en) 1999-05-21
RU2147302C1 (ru) 2000-04-10
WO1997017336A1 (en) 1997-05-15
PT874834E (pt) 2001-04-30
CA2236940A1 (en) 1997-05-15
ES2152564T3 (es) 2001-02-01
AR032373A2 (es) 2003-11-05
NO982051D0 (no) 1998-05-06
BR9611366A (pt) 1999-02-23
JP3152938B2 (ja) 2001-04-03
ATE198071T1 (de) 2000-12-15
HUP9903765A3 (en) 2001-12-28
DK0874834T3 (da) 2001-02-19
DE69611253D1 (de) 2001-01-18
CN1071324C (zh) 2001-09-19
AU7092696A (en) 1997-05-29

Similar Documents

Publication Publication Date Title
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
HUP9601652A1 (en) Piridyl-naphthalene derivatives, process for the preparation thereof, and intermediates thereof
HUP0004388A3 (en) Process for the preparation of oxazolidinones, intermediates and preparation thereof
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
IL117188A0 (en) Process for the preparation of thietanones
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
ZA9710322B (en) Process for the preparation of benzyl-ethers.
IL113850A0 (en) Process and intermediates for the preparation of 3-aryluracils
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
EP0674834A3 (en) Pretzel and method for its preparation.
EP0761718A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
AU5507098A (en) Enhancement of dna immunization through the use of cytokines
HUP9903701A3 (en) Process for the preparation of 2-chlorothiazole derivatives, intermediates and preparation thereof
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
AU1697197A (en) Immunoconjugate for the treatment of aids
HUP9600320A3 (en) Process and new intermediates for the preparation of triazolinon-derivatives
EP0761721A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
AU2173597A (en) Process for the preparation of tenidap
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
ZA969315B (en) Processes and intermediates for the preparation of ziprasidone.
AU2643495A (en) Assay for pathogenicity of anti-dna antibodies
ZA982255B (en) Process for the preparation of arylmalonates.
EP0761719A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.